Skip to main content
M

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 1,180 across all filing types
Latest filing 2022-11-29 Regulatory Filings
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - MEM 4 pages 24.3KB
Regulatory Filings
2022-11-29 English
Chairman and MD address to shareholders 9 pages 178.6KB
Regulatory Filings
2022-11-27 English
Results of Meeting 2 pages 234.8KB
Regulatory Filings
2022-11-27 English
Constitution 74 pages 746.6KB
Regulatory Filings
2022-11-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 308.4KB
Regulatory Filings
2022-10-26 English
Notice of Annual General Meeting/Proxy Form 26 pages 614.9KB
Regulatory Filings
2022-10-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.